Home|For Investor    Magazine    issue page

COVER STORY Vol 32 Issue No 06

Trump Stumped IT And Pharma

Days after Donald Trump took over the Oval office in White House, Indian IT honchos and pharmaceutical industry leaders started feeling the heat of summer even in the spring. Are they prepared enough to tackle the odds posed by the Trump administration and protect interest of their shareholders -- Lohit Bharambe and Abhishek Kumar explore:

More in

This Issue

Editorial

Trump or No Trump, India Success Story Remains Unchanged, Well, Almost

Things are finally easing out and there is a deep sense of comfort everywhe...

Special Report

Q3 Earnings: An Exhaustive Analysis of Six Key Sectors

Karan Bhojwani goes through the third quarter numbers posted by India Inc. ...

Analysis

Bank On IndusInd Even As Merger Talks With Bharat Financial Inclusion Making Rounds

Future of banking and financial services in our country looks extremely pro...

Expert Opinion

Time To Increase Equity Exposure In Your Portfolio

It was widely believed that the Union finance minister will provide some re...

Informed Intelligence

Kerbside

The recommendations provided in this column are taken from various market s...

Market Moves

Economic Policies From Oval Office And GST Meet To Direct Markets

In another development, which is certainly going to have impact on global c...

Technicals

NIfty Index Chart Analysis

Assembly Elections' Outcome To Be Watched For - Keep A Tab On 8730 - 8750

Wassup Trackpad

Trackpad

Trackpad Wassup

DSIJ Magazine Archives

/productAttachment/IssueMaster/Vol.40IssueNo.11.jpg
21 April, 2025
Vol. 40 Issue No. 11
/productAttachment/IssueMaster/Vol.40IssueNo.10.jpg
07 April, 2025
Vol. 40 Issue No. 10
/productAttachment/IssueMaster/Vol.40IssueNo.9.jpg
24 March, 2025
Vol. 40 Issue No. 9
Archive

DSIJ MINDSHARE

Mkt Commentary8-May, 2025

Mindshare8-May, 2025

Mindshare8-May, 2025

Mindshare8-May, 2025

Mindshare8-May, 2025

Knowledge

MF2-May, 2025

MF30-Apr, 2025

Knowledge29-Apr, 2025

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

SEBI Registered Research Analyst Details:
Registered Name: DSIJ PRIVATE LIMITED
Type of registration: Non-Individual
Registration No.: INH000006396
Validity: Oct 05, 2018 - Perpetual
BSE Enlistment No. 5307

SEBI Registered Investment Adviser Details:
Registered Name: DSIJ PRIVATE LIMITED
Type of registration: Non-Individual
Registration No.: INA000001142
Validity: Aug 19, 2019 - Perpetual
BSE Enlistment No. 1346

Registered and Correspondence Office Address :
DSIJ PVT LTD. Office No - 409,
Solitaire Business Hub, Kalyani Nagar, Pune - 411006
Tel: +91 022-43476012/13/14/15 | Email: service@dsij.in
CIN No.: U22120MH2003PTC139276
GST No.: 27AACCR4303G1ZP

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR

Disclaimer: "Registration granted by SEBI, membership of BASL and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors"

Investment in securities market is subject to market risks. Read all the related documents carefully before investing.

Any act of copying, reproducing, or distributing the content whether wholly or in part, for any purpose without the permission of DSIJ is strictly prohibited and shall be deemed to be copyright infringement.

Disclosures | Terms & Conditions | Privacy Statement | WhiteList